+499.5%
MRNA vs VYM
+21.4%
+478.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VYM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.8% | -1.5% |
| 7D | +5.5% | 0.0% | +5.5% | +5.4% |
| 30D | +158.7% | -0.5% | +159.3% | +162.1% |
| 3M | +182.1% | +3.0% | +179.1% | +167.0% |
| 6M | +151.8% | +8.2% | +143.6% | +113.8% |
| YTD | +393.6% | +15.8% | +377.7% | +253.7% |
| 1Y | +499.5% | +20.8% | +478.6% | +300.0% |
| All | +499.5% | +21.4% | +478.0% | +300.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VYM.
Daily Out/Under-Performance
Portfolio return minus VYM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VYM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VYM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling